This study aimed to assess the efficacy of a minimal intervention focusing on hypnotic discontinuation and cognitive-behavioral treatment (CBT) for insomnia. Fifty-three adult chronic users of hypnotics were randomly assigned to an 8-week hypnotic taper program, used alone or combined with a self-help CBT. Weekly hypnotic use decreased in both conditions, from a nearly nightly use at baseline to less than once a week at posttreatment. Nightly dosage (in lorazepam equivalent) decreased from 1.67 mg to 0.12 mg. Participants who received CBT improved their sleep efficiency by 8%, whereas those who did not remained stable. Total wake time decreased by 52 min among CBT participants and increased by 13 min among those receiving the taper schedule alone. Total sleep time remained stable throughout withdrawal in both CBT and taper conditions. The present findings suggest that a systematic withdrawal schedule might be sufficient in helping chronic users stop their hypnotic medication. The addition of a self-help treatment focusing on insomnia, a readily available and cost-effective alternative to individual psychotherapy, produced greater sleep improvement.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1037/0022-006X.75.2.325 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Masked Taper With Behavioral Intervention for Discontinuation of Benzodiazepine Receptor Agonists: A Randomized Clinical Trial.
JAMA Intern Med
December 2024
Geriatric, Research, Education and Clinical Center, VA Greater Los Angeles Healthcare System, Los Angeles, California.
Article Synopsis
- Placebo effects are often seen in clinical trials for benzodiazepine receptor agonists, leading to recommendations for discontinuation of these medications in older adults and the use of cognitive behavioral therapy for insomnia (CBTI) instead.
- This study aims to compare the effects of a masked tapering process combined with enhanced CBTI against standard CBTI with an unmasked taper in helping older adults discontinue benzodiazepine receptor agonists.
- The primary outcome measured is the percentage of participants successfully discontinuing their medication after 6 months, with additional assessments of insomnia severity and short-term discontinuation rates.
Effective alleviation of depressive and anxious symptoms and sleep disorders in benzodiazepine-dependent patients through repetitive transcranial magnetic stimulation.
Addict Biol
July 2024
Department of Psychiatry, Zhenjiang Mental Health Center, Zhenjiang, China.
Benzodiazepine (BZD) dependence poses a significant challenge in mental health, prompting the exploration of treatments like repetitive transcranial magnetic stimulation (rTMS). This research aims to assess the impact of rTMS on alleviating symptoms of BZD dependence. A randomized control trial was employed to study 40 BZD-dependent inpatients.
View Article and Find Full Text PDFImportance of Early Diagnosis and Treatment of Perioperative Catatonia: A Case Report.
J Nippon Med Sch
July 2024
Department of Anesthesiology, Nippon Medical School.
Symptoms of catatonia include silence, motionlessness, and postural retention. Although it is important to detect and treat catatonia early, before it becomes severe, postoperative cases have inherent risks that hinder diagnosis and treatment. A 60-year-old man with schizophrenia underwent endoscopic/thoracoscopic esophagectomy and was extubated in the operating room.
View Article and Find Full Text PDFTreating Benzodiazepine Withdrawal in a Bridge Clinic.
J Addict Med
November 2024
From the Grayken Center for Addiction, Department of Medicine, Boston University School of Medicine and Boston Medical Center, Boston, MA (JL, TWK, JLT); Boston Health Care for the Homeless Program, Boston, MA (JL, MY); Department of Internal Medicine, University of Colorado School of Medicine, Aurora, CO (PJC); Department of General Internal Medicine, Denver Health and Hospital Authority, Denver, CO (PJC); The Dimock Center, Boston, MA (JE); Department of Quality and Patient Safety, Boston Medical Center, Boston, MA (NMF); Department of Emergency Medicine, Boston University School of Medicine, Boston, MA (NMF); New England Medical Group, Hingham, MA (JK); and Ascend Integrative Medicine, Boston, MA (JK).
Article Synopsis
- Benzodiazepine overdose deaths are increasing due to the rise in nonprescribed use, making outpatient tapering protocols essential for patients wanting to stop usage safely.
- A study implemented a 4- to 6-week outpatient taper protocol with diazepam for patients with benzodiazepine use disorder, aiming to assess its outcomes in a substance use disorder bridge clinic.
- Out of 54 patients who started the taper, the majority were male and experienced in substance use, with many also dealing with opioid use disorder, highlighting the need for comprehensive support during the tapering process.
Article Synopsis
- Chronic insomnia is prevalent and impacts quality of life; benzodiazepine hypnotics are often used but can have side effects like dependence and impaired concentration.
- Lemborexant (LEM), an orexin receptor antagonist, was assessed in a study with 28 patients to see its effectiveness on sleep and if it could help taper benzodiazepine use.
- Results showed significant improvements in insomnia symptoms and a notable reduction in benzodiazepine dosage after LEM treatment, suggesting LEM may be a safer alternative for managing insomnia.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!